DnB Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.7M | Sell |
|
|||||
|
2025
Q1 | $85.6M | Sell |
|
|||||
|
2024
Q4 | $80.9M | Buy |
|
|||||
|
2024
Q3 | $84.5M | Buy |
|
|||||
|
2024
Q2 | $78.1M | Sell |
|
|||||
|
2024
Q1 | $79.9M | Sell |
|
|||||
|
2023
Q4 | $80.7M | Buy |
|
|||||
|
2023
Q3 | $66.8M | Sell |
|
|||||
|
2023
Q2 | $73.4M | Sell |
|
|||||
|
2023
Q1 | $89.4M | Sell |
|
|||||
|
2022
Q4 | $86.6M | Sell |
|
|||||
|
2022
Q3 | $91.5M | Sell |
|
|||||
|
2022
Q2 | $97.3M | Sell |
|
|||||
|
2022
Q1 | $91.7M | Sell |
|
|||||
|
2021
Q4 | $107M | Sell |
|
|||||
|
2021
Q3 | $92.5M | Buy |
|
|||||
|
2021
Q2 | $85.4M | Buy |
|
|||||
|
2021
Q1 | $15.9M | Buy |
|
|||||
|
2020
Q4 | $9.09M | Buy |
|
|||||
|
2020
Q3 | $9.45M | Buy |
|
|||||
|
2020
Q2 | $9.34M | Buy |
|
|||||
|
2020
Q1 | $6.4M | Sell |
|
|||||
|
2019
Q4 | $7.04M | Buy |
|
|||||
|
2019
Q3 | $4.7M | Buy |
|
|||||
|
2019
Q2 | $4.73M | Sell |
|
|||||
|
2019
Q1 | $5.05M | Sell |
|
|||||
|
2018
Q4 | $5.06M | Sell |
|
|||||
|
2018
Q3 | $6.29M | Buy |
|
|||||
|
2018
Q2 | $5.37M | Buy |
|
|||||
|
2018
Q1 | $4.76M | Buy |
|
|||||
|
2017
Q4 | $3.94M | Buy |
|
|||||
|
2017
Q3 | $3.9M | Sell |
|
|||||
|
2017
Q2 | $3.32M | Sell |
|
|||||
|
2017
Q1 | $2.9M | Buy |
|
|||||
|
2016
Q4 | $1.65M | Buy |
|
|||||
|
2016
Q3 | $1.85M | Buy |
|
|||||
|
2016
Q2 | $1.7M | Buy |
|
|||||
|
2016
Q1 | $1.45M | Buy |
|
|||||
|
2015
Q4 | $1.71M | Sell |
|
|||||
|
2015
Q3 | $3.33M | Sell |
|
|||||
|
2015
Q2 | $6.43M | Buy |
|
|||||
|
2015
Q1 | $5.02M | Sell |
|
|||||
|
2014
Q4 | $6.69M | Buy |
|
|||||
|
2014
Q3 | $6.2M | Buy |
|
|||||
|
2014
Q2 | $3.32M | Buy |
|
|||||
|
2013
Q4 | $4.69M | Buy |
|